The results indicated that highly-expressed COL5A2 appeared in 18 of 20 tumor types, especially in breast, gastric, colorectal, and head and neck cancers (Figure 1a), which was consistent with the findings of several previous studies [18,19]. This evidence concerns the gene COL5A2 and neoplasm.